Parul Dixit1, Hayden Donnelly1, Midori Edamatsu1, Ivor Galvin2, Richard Bunton2, Rajesh Katare3. 1. Department of Physiology-HeartOtago, University of Otago, Dunedin, New Zealand. 2. Department of Cardiothoracic Surgery, University of Otago, Dunedin, New Zealand. 3. Department of Physiology-HeartOtago, University of Otago, Dunedin, New Zealand. Electronic address: rajesh.katare@otago.ac.nz.
Abstract
AIM: Deciding the best cell type for cardiac regeneration remains a big challenge. No studies have directly compared the functional efficacy of cardiac progenitor cells (CPCs) with extra-cardiac stem cells isolated from the same patient. METHODS AND RESULTS: We compared the functional characteristics of endothelial progenitor cells (EPCs), right atrial (RAA) CPCs and left ventricular (LV) CPCs isolated from the same patients (n=14). Within the same heart, RAA and LV CPCs exhibited marked differences in surface marker expression, with RAA CPCs exhibiting better expansion potential and migration properties. When subjected to hypoxia and serum starvation to simulate in vivo ischemic environment, RAA and LV CPCs exhibited similar pattern of resistance to apoptotic cell death under ischemia. Interestingly, EPCs exhibited highest resistance to apoptotic cell death, however, they also showed the lowest proliferation under hypoxia. RT-profiler array showed comparable gene expression pattern in RAA and LV CPCs, while they were differentially expressed in EPCs. Further, treating human umbilical vein endothelial cells with conditioned medium (CM) from LV showed maximum angiogenic potential, while cardiomyocytes treated with CM from RAA showed greatest survival under hypoxic conditions. CONCLUSIONS: Results from this study provide the first evidence that progenitor cells from different regions exhibit functional differences within the same patient.
AIM: Deciding the best cell type for cardiac regeneration remains a big challenge. No studies have directly compared the functional efficacy of cardiac progenitor cells (CPCs) with extra-cardiac stem cells isolated from the same patient. METHODS AND RESULTS: We compared the functional characteristics of endothelial progenitor cells (EPCs), right atrial (RAA) CPCs and left ventricular (LV) CPCs isolated from the same patients (n=14). Within the same heart, RAA and LV CPCs exhibited marked differences in surface marker expression, with RAA CPCs exhibiting better expansion potential and migration properties. When subjected to hypoxia and serum starvation to simulate in vivo ischemic environment, RAA and LV CPCs exhibited similar pattern of resistance to apoptotic cell death under ischemia. Interestingly, EPCs exhibited highest resistance to apoptotic cell death, however, they also showed the lowest proliferation under hypoxia. RT-profiler array showed comparable gene expression pattern in RAA and LV CPCs, while they were differentially expressed in EPCs. Further, treating human umbilical vein endothelial cells with conditioned medium (CM) from LV showed maximum angiogenic potential, while cardiomyocytes treated with CM from RAA showed greatest survival under hypoxic conditions. CONCLUSIONS: Results from this study provide the first evidence that progenitor cells from different regions exhibit functional differences within the same patient.
Authors: Nima Purvis; Sweta Kumari; Dhananjie Chandrasekera; Jayanthi Bellae Papannarao; Sophie Gandhi; Isabelle van Hout; Sean Coffey; Richard Bunton; Ramanen Sugunesegran; Dominic Parry; Philip Davis; Michael J A Williams; Andrew Bahn; Rajesh Katare Journal: Diabetologia Date: 2021-03-02 Impact factor: 10.122
Authors: Ramakanth Satthenapalli; Scott Lee; Jayanthi Bellae Papannarao; Timothy A Hore; Akash Chakraborty; Peter P Jones; Regis R Lamberts; Rajesh Katare Journal: Stem Cell Res Ther Date: 2022-05-06 Impact factor: 6.832
Authors: Ingrid Fomison-Nurse; Eugene Eng Leng Saw; Sophie Gandhi; Pujika Emani Munasinghe; Isabelle Van Hout; Michael J A Williams; Ivor Galvin; Richard Bunton; Philip Davis; Vicky Cameron; Rajesh Katare Journal: Cell Death Differ Date: 2018-01-04 Impact factor: 15.828
Authors: Shruti Rawal; Prashanth Thevakar Nagesh; Sean Coffey; Isabelle Van Hout; Ivor F Galvin; Richard W Bunton; Philip Davis; Michael J A Williams; Rajesh Katare Journal: Cardiovasc Diabetol Date: 2019-01-29 Impact factor: 9.951